Agenus (AGEN) Cash from Investing Activities (2010 - 2026)
Agenus (AGEN) posted quarterly Cash from Investing Activities of $69.0 million for Q1 2026, up 120868.42% year-over-year from N/an in Q1 2025, and up 8740.0% quarter-over-quarter from $780000.0 in Q4 2025.
Powered by 
Analysis
Agenus (AGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Agenus' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $69.0 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 120868.42% year-over-year to $69.0 million; the TTM figure through Mar 2026 stood at $70.1 million (up 48437.24% YoY), while the FY2025 annual figure was $1.2 million, up 4322.22% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $69.0 million, up from $780000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $69.0 million in Q1 2026, with the low at -$15.6 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is $57000.0 (2025), against an average of $2.4 million.
- The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities slumped 3743.37% in 2022, then surged 120868.42% in 2026.
- Agenus' Cash from Investing Activities stood at -$6.4 million in 2022, then jumped by 144.24% to $2.8 million in 2023, then sank by 100.74% to -$21000.0 in 2024, then jumped by 3814.29% to $780000.0 in 2025, then jumped by 8740.0% to $69.0 million in 2026.
- Business Quant data shows AGEN's Cash from Investing Activities at $69.0 million in Q1 2026, $780000.0 in Q4 2025, and $76000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Agenus | 344.35 Mn | 344.35 Mn | 34.52 Mn | 267,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 267,000.00 |
| Mar 31, 2026 | 68.95 Mn |
| Dec 31, 2025 | 780,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | -21,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Mar 31, 2024 | 229,000.00 |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 11.55 Mn |
| Jun 30, 2023 | 517,000.00 |
| Mar 31, 2023 | -11.49 Mn |
| Dec 31, 2022 | -6.38 Mn |
| Sep 30, 2022 | -15.64 Mn |
| Jun 30, 2022 | -4.06 Mn |
| Mar 31, 2022 | -7.53 Mn |
| Dec 31, 2021 | -13.30 Mn |
| Sep 30, 2021 | -27.39 Mn |